Feb 6 (Reuters) - Acutus Medical Inc AFIB.O :
* LATE-BREAKING ACQFORCE FLUTTER TRIAL MEETS PRIMARY
ENDPOINT FOR
SAFETY AND EFFICACY WITH THE FIRST GOLD-TIPPED CONTACT FORCE
SENSING ABLATION CATHETER
* ACUTUS MEDICAL INC - ACUTE SUCCESS WAS ACHIEVED IN 94% OF
PATIENTS AND THERE WERE NO SERIOUS ADVERSE EVENTS
* ACUTUS MEDICAL INC - STUDY DEMONSTRATED COMPARABLE
OUTCOMES TO
HISTORIC CONTROLS WITH SIGNIFICANTLY SHORTER ABLATION TIME AND
LOWER FLUID VOLUMES
* ACUTUS MEDICAL INC-SUBMITTED PREMARKET APPROVAL
APPLICATION FOR
ACQBLATE FORCE SENSING ABLATION CATHETER, SYSTEM ON OCT 3, 2022,
IS CURRENTLY UNDER REVIEW
Source text for Eikon: ID:nGNX3qG4Km
Further company coverage: AFIB.O
((Reuters.Briefs@thomsonreuters.com;))